Drug Discovery and Development

Owkin signs deal with Merck to create and market AI-driven cancer diagnostics

Owkin, a biotech powerhouse blending French finesse with American innovation, has struck a collaboration chord with MSD, also known as Merck & Co. Inc. This duo aims to revolutionize...

The Revolutionary Path of Single-Use Dual-Channel...

Insights

In the field of urology, ureteroscopic...

CDC: Three Veterinarians Had H5N1 Without...

News

The latest report from the CDC...

Pharma Logistics and Rx Reverse Distributors...

News

Pharma Logistics, LLC and Rx Reverse...

Revolutionizing Healthcare: The Dawn of AI-Driven...

Digital Health Transformation

The realm of healthcare is witnessing...

Surviving the MedTech Gauntlet: Insights for...